Home » Topics » BioWorld Science

BioWorld Science
RSS

A7-183: Effective topical therapy of recurrent herpes labialis and genitalis

June 7, 1996

Xoma granted U.S. patent for use of BPI

June 7, 1996

Kyowoa Hakko's RP-1551-2: a novel antimicrobial agent

June 7, 1996

Glaxo Wellcome and Otsuka sign grepafloxacin licensing agreement

June 7, 1996

Favorable trial results with interferon gamma-1b for atopic dermatitis and keloids

June 7, 1996

Collagen Corp. acquires distribution rights to Tissue Technologies' ePTFE implant

June 7, 1996

Synthetic retinoid analogue cleared for U.S. market

June 7, 1996

Pfizer reveals migraine treatment

June 7, 1996

Oclassen obtains rights to 5-MOP

June 7, 1996

Controlled-release oxycodone HCl now on U.S. shelves

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.